42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
    [defid] => VWS-WOO-08-1260591
    [request_id] => 
)

=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
    [id] => c2d2693d-b7bb-4658-bc9a-d88deed091a1
    [Document ID] => 1260591
    [Document naam] => RE: Availability and allocation of investigational plasma-derivedtherapy against COVID-19
    [Bestandsnaam] => 
    [Beoordeling] => 
    [Beoordelingsgrond] => 
    [Toelichting] => 
    [Publieke link] => 
    [Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/document/VWS-WOO-08-1260591
    [Opgeschort] => 
    [Definitief ID] => VWS-WOO-08-1260591
    [Status] => 
    [FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo
    [DocumentPublicationDate] => 16 april 2021
    [DocumentStatusCheckedDate] => 
    [DocumentStatusCheckedResult] => 
    [SourceFileType] => 
    [Tags] => 
    [Besluit] => 
    [ModifiedDate] => 2025-09-22 08:20:02
    [DeletedDate] => 
    [BesluitURL] => 
    [CreatedDate] => 2025-06-19 18:31:59
    [DocumentDownloadLink] => 
    [DigestLaatsteControleDatum] => 2025-09-22 08:20:02
)

Document: VWS-WOO-08-1260591

Pagina 1 preview
Klik om te vergroten

Document correcties

Geregistreerde datum: 20210416

Geregistreerde documentnaam: RE: Availability and allocation of investigational plasma-derivedtherapy against COVID-19

Document metadata

Metadata tonen (25 velden)
VeldWaarde
idc2d2693d-b7bb-4658-bc9a-d88deed091a1
Document ID1260591
Document naamRE: Availability and allocation of investigational plasma-derivedtherapy against COVID-19
Bestandsnaamleeg!
Beoordelingleeg!
Beoordelingsgrondleeg!
Toelichtingleeg!
Publieke linkleeg!
Locatie open.minvws.nlhttps://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/document/VWS-WOO-08-1260591
Opgeschortleeg!
Definitief IDVWS-WOO-08-1260591
Statusleeg!
FromFilehttps://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo
DocumentPublicationDate16 april 2021
DocumentStatusCheckedDateleeg!
DocumentStatusCheckedResultleeg!
SourceFileTypeleeg!
Tagsleeg!
Besluitleeg!
ModifiedDate2025-09-22 08:20:02
DeletedDateleeg!
BesluitURLleeg!
CreatedDate2025-06-19 18:31:59
DocumentDownloadLinkleeg!
DigestLaatsteControleDatum2025-09-22 08:20:02

🧙 User tags

Nog geen user tags

Document attributen

TagWaardeDatum
About_Gelakte gegevens_linkhref_3mailto:DienstpostbusDatalekkenDoo@minvws.nl2025-09-02 07:48:04
About_Gelakte gegevens5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.2h De beveiliging van personen of bedrijven en het voorkomen van sabotage Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten2025-09-02 07:48:04
document_SectionDownloadButton12025-09-02 07:48:04
document_documentNumberVWS-WOO-08-12605912025-06-30 02:11:01
document_SectionDownloadButton02025-06-30 02:11:01
document_SectionHTMLDataDivs42025-06-30 02:11:01
document_SectionAbout12025-06-30 02:11:01
About_Datum document16 april 20212025-06-30 02:11:01
About_Type bronbestandE-mailbericht, 4 pagina's2025-06-30 02:11:01
About_Type bronbestand_paginas42025-06-30 02:11:01
About_Download alsPDF (2.44 MB)2025-06-30 02:11:01
About_Documentnummer12605912025-06-30 02:11:01
document_documentNameRE: Availability and allocation of investigational plasma-derivedtherapy against COVID-192025-06-30 02:11:01
About_Gelakte gegevens5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.2h De beveiliging van personen of bedrijven en het voorkomen van sabotage Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten.2025-06-30 02:11:01
About_Gelakte gegevens_linkhref_1https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-30 02:11:01
About_Gelakte gegevens_linkname_15.1.2e Eerbiediging van de persoonlijke levenssfeer2025-06-30 02:11:01
About_Gelakte gegevens_linkhref_2https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-30 02:11:01
About_Gelakte gegevens_linkname_25.1.2h De beveiliging van personen of bedrijven en het voorkomen van sabotage2025-06-30 02:11:01
About_Gelakte gegevens_linkhref_3mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over RE: Availability and allocation of investigational plasma-derivedtherapy against COVID-19 (documentnummer 1eec1b43-5a12-6c0a-a0f9-bb3705657b16)2025-06-30 02:11:01
About_Gelakte gegevens_linkname_3Laat het ons weten2025-06-30 02:11:01
document_SectionLinked12025-06-30 02:11:01
document_SectionRequest12025-06-30 02:11:01
Request_Onderdeel vanWoo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 20212025-06-30 02:11:01
Request_Onderdeel van_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo2025-06-30 02:11:01
Request_Onderdeel van_linkname_1Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 20212025-06-30 02:11:01
Request_Samenvatting verzoekDe minister van Volksgezondheid, Welzijn en Sport heeft op 23 november 2023 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties & Medicatie maart 2021.2025-06-30 02:11:01
Request_PeriodeMaart 20212025-06-30 02:11:01
Request_Type besluitWoo-besluit2025-06-30 02:11:01
Request_Datum besluit23 november 20232025-06-30 02:11:01
Request_Omvang openbaarmaking15.961 documenten, 29.047 pagina's Inventarislijst2025-06-30 02:11:01
Request_Omvang openbaarmaking_documenten15.9612025-06-30 02:11:01
Request_Omvang openbaarmaking_paginas29.0472025-06-30 02:11:01
Request_Omvang openbaarmaking_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/inventory2025-06-30 02:11:01
Request_Omvang openbaarmaking_linkname_1Inventarislijst2025-06-30 02:11:01
document_SectionHistory12025-06-30 02:11:01
About_BeoordelingGedeeltelijke openbaarmaking2025-06-30 02:11:01
document_documentTypeE-mailbericht2025-06-30 02:11:01
document_documentPublicationDate2021-04-162025-06-30 02:11:01
History Datum_130 mei 2024 19:372025-06-19 12:14:32
History Datum_330 mei 2024 18:392025-06-19 12:14:32
History Actie_3Bronbestand vervangen (pdf, 2.44 MB)2025-06-19 12:14:32
History Datum_430 mei 2024 17:082025-06-19 12:14:32
History Actie_4Bronbestand vervangen (pdf, 2.44 MB)2025-06-19 12:14:32
History Datum_530 mei 2024 16:542025-06-19 12:14:32
History Actie_5Bronbestand vervangen (pdf, 2.44 MB)2025-06-19 12:14:32
History Datum_630 mei 2024 15:212025-06-19 12:14:32
History Actie_6Bronbestand vervangen (pdf, 2.44 MB)2025-06-19 12:14:32
History Datum_730 mei 2024 15:082025-06-19 12:14:32
History Actie_7Bronbestand toegevoegd (pdf, 2.44 MB)2025-06-19 12:14:32
History Datum_230 mei 2024 19:322025-06-19 12:14:32
History Actie_1Bronbestand vervangen (pdf, 2.44 MB)2025-06-19 12:14:32
History Actie_2Bronbestand vervangen (pdf, 2.44 MB)2025-06-19 12:14:32
DocumentDownload_linknameDownload (pdf, 2.44 MB)2025-04-19 21:05:04
DocumentDownload_linkhrefhttps://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/document/1eec1b43-5a12-6c0a-a0f9-bb3705657b162025-04-19 21:05:04
DocumentDownload_proposed_filename (lokale kopie)VWS-WOO-08-1260591.pdf2025-04-19 21:05:04

Archiefversies (6 rijen)

Archiefrij 1 — 2025-09-07 17:26:08
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1260591.pdf
documentName: VWS-WOO-08-1260591.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 2560641
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:26:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:26:08
lastSeen: 2025-09-07 17:26:08
text: 1260591 @minvws.nl]; [EEE @minvws.nl];A. A. A.EES @minvws.nl] )5.1.2¢ Sent:Fri4/16/2021 8:08:19 AM Subject: RE: Availability and allocation ofinvestigational plasma-derivedtherapy against COVID-19 Received:Fri4/16/2021 8:08:20 AM Thank you forthe information onthe ITAC trial outcomes. Weunderstand t...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 84758d41e9a64b79ce2c75f016a64b007a64bc76b5f20b9eafb031637de52fa7
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_48300_66a9d367fe769f345f8a575190fc533e
textDigestSHA256: 35e000a63d8f9eadde6028c00eee61f6ff9dd7b13ed189226dd15894d23cfe0c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1260591
Archiefrij 2 — 2025-09-04 17:12:23
fromFile: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
documentName: VWS-WOO-08-1260591.pdf
documentType: pdf
documentCompressedSize: 2005014
documentSize: 2560641
documentCompressRatio: 78.30125347520406
documentDateModified: 2025-05-01 20:27:52
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:12:23
lastSeen: 2025-09-04 17:12:23
text: 1260591 @minvws.nl]; @minvws.nl]; Sent: Subject: Received: A. A. 5.1.2¢ A. EES [EEE @minvws.nl] ) Fri 4/16/2021 8:08:19 AM RE: Availability and allocation of investigational plasma-derivedtherapy against COVID-19 Fri 4/16/2021 8:08:20 AM Thank you for t...
noTextDate: leeg!
ocrText: 1227720 Artikel ArtikeIType, ArtikelFarmaceut ArtikelDescription ArtikelCategorie ArtikelAantal ArtikelEenheid, ArtikelHoeveelheid, ArtikelHoeveelheid Flacons,ArtikelHoeveelheidDosesPerTray ArtikelHoeveelheidDoses, ArtikelAfnemer ArtikelAfnemerGroep, ArtikelAfgiftedatum , ArtikelStatus, ArtikelAfze...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 84758d41e9a64b79ce2c75f016a64b007a64bc76b5f20b9eafb031637de52fa7
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip_338
textDigestSHA256: ea0b981bf825f6dde05cd8eaad47c0b7290c57ece4b5f870acbb3623a168e912
ocrTextDigestSHA256: cbb318e36bc801b51a4e835f266ccf9e2f2591f7587882f9cceab6e8131f83fb
extractedId: VWS-WOO-08-1260591
Archiefrij 3 — 2025-09-04 17:10:20
fromFile: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
documentName: VWS-WOO-08-1260591.pdf
documentType: pdf
documentCompressedSize: 2005014
documentSize: 2560641
documentCompressRatio: 78.30125347520406
documentDateModified: 2025-05-01 20:27:52
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:10:20
lastSeen: 2025-09-04 17:10:20
text: 1260591 @minvws.nl]; @minvws.nl]; Sent: Subject: Received: A. A. 5.1.2¢ A. EES [EEE @minvws.nl] ) Fri 4/16/2021 8:08:19 AM RE: Availability and allocation of investigational plasma-derivedtherapy against COVID-19 Fri 4/16/2021 8:08:20 AM Thank you for t...
noTextDate: leeg!
ocrText: isoweek-2021 isoweek-2022 |Ct-waarde 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 84758d41e9a64b79ce2c75f016a64b007a64bc76b5f20b9eafb031637de52fa7
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip_338
textDigestSHA256: ea0b981bf825f6dde05cd8eaad47c0b7290c57ece4b5f870acbb3623a168e912
ocrTextDigestSHA256: 34ea7743594f08b217c2e155c1f4035ef17e172d69327d310aa73507055b967b
extractedId: VWS-WOO-08-1260591
Archiefrij 4 — 2025-03-18 09:30:26
fromFile: 2024.075-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1260591-RE_Availability_and_allocation_of_investigational_plasma-derivedtherapy_against_COVID-19.pdf
documentType: pdf
documentCompressedSize: 2001088
documentSize: 2560641
documentCompressRatio: 78.14793249034129
documentDateModified: 2024-10-25 13:32:30
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:26
lastSeen: 2025-03-18 09:30:26
text: 1260591 @minvws.nl]; [EEE @minvws.nl];A. A. A.EES @minvws.nl] )5.1.2¢ Sent:Fri4/16/2021 8:08:19 AM Subject: RE: Availability and allocation ofinvestigational plasma-derivedtherapy against COVID-19 Received:Fri4/16/2021 8:08:20 AM Thank you forthe information onthe ITAC trial outcomes. Weunderstand t...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 35e000a63d8f9eadde6028c00eee61f6ff9dd7b13ed189226dd15894d23cfe0c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 356969
textDigestSHA256: 35e000a63d8f9eadde6028c00eee61f6ff9dd7b13ed189226dd15894d23cfe0c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1260591
Archiefrij 5 — 2025-02-27 09:25:06
fromFile: 2022.252-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2022.252-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1260591-RE_Availability_and_allocation_of_investigational_plasma-derivedtherapy_against_COVID-19.pdf
documentType: pdf
documentCompressedSize: 2001088
documentSize: 2560641
documentCompressRatio: 78.14793249034129
documentDateModified: 2024-10-25 13:32:30
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:06
lastSeen: 2025-02-27 09:25:06
text: 1260591 @minvws.nl]; [EEE @minvws.nl];A. A. A.EES @minvws.nl] )5.1.2¢ Sent:Fri4/16/2021 8:08:19 AM Subject: RE: Availability and allocation ofinvestigational plasma-derivedtherapy against COVID-19 Received:Fri4/16/2021 8:08:20 AM Thank you forthe information onthe ITAC trial outcomes. Weunderstand t...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 8, "email": "@minvws.nl", "context": "1260591 @minvws.nl]; [EEE @minvws.nl];A. A."}, {"position": 26, "email": "@minvws.nl", "context": "1260591 @minvws.nl]; [EEE @minvws.nl];A. A. A.EES @minvws.nl]"}, {"position": 50, "email": "@minvws.nl", "context": "@minvws.nl];A. A. A.EES @minvws.nl] )5.1.2\u00a2 Sent:Fri4/16/2021 8:08:19"}, {"position": 733, "email": "@minvws.nl", "context": "6april 2021 14:04 @minvws.nl>; 5.1.2e Onderwerp: Availability"}, {"position": 2021, "email": "@minvws.nl", "context": "5.1.2e 5.1.2e a @minvws.nl>; 5.1.2e Subject: RE:Availability"}]
documentMailAdresses: [{"position": 8, "email": "@minvws.nl", "context": "1260591 @minvws.nl]; [EEE @minvws.nl];A. A."}, {"position": 26, "email": "@minvws.nl", "context": "1260591 @minvws.nl]; [EEE @minvws.nl];A. A. A.EES @minvws.nl]"}, {"position": 50, "email": "@minvws.nl", "context": "@minvws.nl];A. A. A.EES @minvws.nl] )5.1.2\u00a2 Sent:Fri4/16/2021 8:08:19"}, {"position": 733, "email": "@minvws.nl", "context": "6april 2021 14:04 @minvws.nl>; 5.1.2e Onderwerp: Availability"}, {"position": 2021, "email": "@minvws.nl", "context": "5.1.2e 5.1.2e a @minvws.nl>; 5.1.2e Subject: RE:Availability"}]
digestSHA256: 35e000a63d8f9eadde6028c00eee61f6ff9dd7b13ed189226dd15894d23cfe0c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 270139
textDigestSHA256: 35e000a63d8f9eadde6028c00eee61f6ff9dd7b13ed189226dd15894d23cfe0c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1260591
Archiefrij 6 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
documentName: VWS-WOO-08-1260591-RE_Availability_and_allocation_of_investigational_plasma-derivedtherapy_against_COVID-19.pdf
documentType: pdf
documentCompressedSize: 2001088
documentSize: 2560641
documentCompressRatio: 78.14793249034129
documentDateModified: 2024-10-25 13:32:30
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1260591 @minvws.nl]; [EEE @minvws.nl];A. A. A.EES @minvws.nl] )5.1.2¢ Sent:Fri4/16/2021 8:08:19 AM Subject: RE: Availability and allocation ofinvestigational plasma-derivedtherapy against COVID-19 Received:Fri4/16/2021 8:08:20 AM Thank you forthe information onthe ITAC trial outcomes. Weunderstand t...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 8, "email": "@minvws.nl", "context": "1260591 @minvws.nl]; [EEE @minvws.nl];A. A."}, {"position": 26, "email": "@minvws.nl", "context": "1260591 @minvws.nl]; [EEE @minvws.nl];A. A. A.EES @minvws.nl]"}, {"position": 50, "email": "@minvws.nl", "context": "@minvws.nl];A. A. A.EES @minvws.nl] )5.1.2\u00a2 Sent:Fri4/16/2021 8:08:19"}, {"position": 733, "email": "@minvws.nl", "context": "6april 2021 14:04 @minvws.nl>; 5.1.2e Onderwerp: Availability"}, {"position": 2021, "email": "@minvws.nl", "context": "5.1.2e 5.1.2e a @minvws.nl>; 5.1.2e Subject: RE:Availability"}]
documentMailAdresses: [{"position": 8, "email": "@minvws.nl", "context": "1260591 @minvws.nl]; [EEE @minvws.nl];A. A."}, {"position": 26, "email": "@minvws.nl", "context": "1260591 @minvws.nl]; [EEE @minvws.nl];A. A. A.EES @minvws.nl]"}, {"position": 50, "email": "@minvws.nl", "context": "@minvws.nl];A. A. A.EES @minvws.nl] )5.1.2\u00a2 Sent:Fri4/16/2021 8:08:19"}, {"position": 733, "email": "@minvws.nl", "context": "6april 2021 14:04 @minvws.nl>; 5.1.2e Onderwerp: Availability"}, {"position": 2021, "email": "@minvws.nl", "context": "5.1.2e 5.1.2e a @minvws.nl>; 5.1.2e Subject: RE:Availability"}]
digestSHA256: 35e000a63d8f9eadde6028c00eee61f6ff9dd7b13ed189226dd15894d23cfe0c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 59275
textDigestSHA256: 35e000a63d8f9eadde6028c00eee61f6ff9dd7b13ed189226dd15894d23cfe0c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1260591

(dit is ook een speeltuin)